null

SMILES: CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cncc(c3)-c3nnc(C)o3)c2)CC1

InChI Key: InChIKey=SRWSCJJFUPPXPK-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 481134   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Mast/stem cell growth factor receptor Kit (Homo sapiens (Human))	BDBM481134 (US10906896, Cpd 8130) Show SMILES CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cncc(c3)-c3nnc(C)o3)c2)CC1 Show InChI InChI=1S/C32H33N9O2/c1-21-4-9-27(35-30(42)24-7-5-23(6-8-24)20-41-14-12-40(3)13-15-41)17-29(21)37-32-34-11-10-28(36-32)25-16-26(19-33-18-25)31-39-38-22(2)43-31/h4-11,16-19H,12-15,20H2,1-3H3,(H,35,42)(H,34,36,37)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	44	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inhibikase Therapeutics, Inc. US Patent					Assay Description Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...				US Patent US10906896 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase ABL1 (Homo sapiens (Human))	BDBM481134 (US10906896, Cpd 8130) Show SMILES CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cncc(c3)-c3nnc(C)o3)c2)CC1 Show InChI InChI=1S/C32H33N9O2/c1-21-4-9-27(35-30(42)24-7-5-23(6-8-24)20-41-14-12-40(3)13-15-41)17-29(21)37-32-34-11-10-28(36-32)25-16-26(19-33-18-25)31-39-38-22(2)43-31/h4-11,16-19H,12-15,20H2,1-3H3,(H,35,42)(H,34,36,37)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	323	n/a	n/a	n/a	n/a	n/a	n/a
Inhibikase Therapeutics, Inc. US Patent					Assay Description Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...				US Patent US10906896 (2021)
					More data for this Ligand-Target Pair
Tyrosine-protein kinase ABL2 (Homo sapiens (Human))	BDBM481134 (US10906896, Cpd 8130) Show SMILES CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cncc(c3)-c3nnc(C)o3)c2)CC1 Show InChI InChI=1S/C32H33N9O2/c1-21-4-9-27(35-30(42)24-7-5-23(6-8-24)20-41-14-12-40(3)13-15-41)17-29(21)37-32-34-11-10-28(36-32)25-16-26(19-33-18-25)31-39-38-22(2)43-31/h4-11,16-19H,12-15,20H2,1-3H3,(H,35,42)(H,34,36,37)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	423	n/a	n/a	n/a	n/a	n/a	n/a
Inhibikase Therapeutics, Inc. US Patent					Assay Description Kinase base buffer (50 mM HEPES, pH 7.5 0.0015% Brij-35; 10 mM MgCl2 2 mM DTT) and Stop buffer, (100 mM HEPES, pH 7.5 0.015% Brij-35; 0.2% Coating Re...				US Patent US10906896 (2021)
					More data for this Ligand-Target Pair